Insilico and SK Biopharm ink $2.5 billion AI drug discovery deal
The partnership targets neuroimmune and CNS disorders using Insilico's Pharma.AI engine, with $18 million in upfront payments and milestone-based upside.
Trending Now
ARPA-H Awards $160 Million for AI-Enabled Personalized Gene Editing to Tackle Rare Diseases
ARPA-H has awarded up to $160 million to seven research teams to build AI-driven platforms for creating custom, individualized gene…
New 3D AI eye model sharpens retinal disease detection and trial design
OCTCube-M reads full volumetric OCT scans to improve retinal disease detection, cut…
Chai Discovery raises $400M at $3.8B valuation for AI drug design
The AI biotech startup triples its valuation in eight months with backing…
Stanford Health AI Week Highlights AI’s Growing Role in Medical Education, Patient Empowerment, and Life Sciences
Stanford Medicine's weeklong Health AI event across eight symposia explored how AI is empowering patients, reshaping medical education, accelerating cancer…
AI Emerges as a Game-Changer in Humanitarian Healthcare Crisis Response
AI is being harnessed to transform humanitarian healthcare, improving disaster response, disease surveillance, mental health…
HKUST Pioneers Micro-Robotics and AI Tools to Reshape Global Healthcare
From ultra-miniature surgical robots to gamified respiratory monitors, HKUST is redefining medical technology with innovations…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…
Healthcare AI faces new risk from cognitive spoofing and fake expertise
Regard CMO Dr. David Kirk warns that AI's polished, authoritative-sounding responses can mask gaps in…
Optibrium Secures Strategic Financing From Shawbrook to Accelerate Global Drug Discovery Innovation
The AI-driven drug discovery leader lands multi-million-pound deal with Shawbrook to fuel technological advancement and…
AI Health Platform and At Home Testing Company Join Forces for Integrated Care
The integrated service connects patients from AI symptom assessment through home testing to virtual clinical…
Chai Discovery raises $400M at $3.8B valuation for AI drug design
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer…
ChatGPT Aids Rare Diagnosis as Tech Giants Accelerate AI Revolution in Healthcare
A Reddit user credited ChatGPT with diagnosing a rare genetic condition after years of medical…
Bridging the Gap: Translating AI Innovations into Neurological Practice
A new review in Nature Reviews Neurology examines the barriers preventing AI tools from moving…
Google’s AMIE AI Advances from Diagnosis to Long-Term Disease Management in New Nature Study
Google’s AMIE AI now manages chronic conditions over time, matching clinicians in reasoning and outperforming…
High-Quality Data Is Key to Unlocking AI’s Full Potential in Clinical Trials
AI is streamlining clinical trials and cutting drug development costs, but success hinges on data…